Effectiveness of treating NELL1-positive idiopathic membranous nephropathy on clinical outcomes, serum cytokine levels (IL-6, IL-10, IL-2, IL-17), nutritional status, and immune responses
Combining GCs and TAC is an effective and safe therapeutic option for NELL1-positive IMN. It improves clinical outcomes, maintains nutritional stability, and modulates immune responses without increasing adverse reactions.
Authors
- Shuo Li (ORCID: https://orcid.org/0000-0002-5184-3230)
- Yanqiu Yu
- Kang Li (ORCID: https://orcid.org/0009-0007-6642-3259)
Institutions
- Cangzhou Central Hospital (CN)
Publication Details
- Journal
- Journal of Medical Biochemistry
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5937/jomb0-56892
- Primary Topic
- Genetic and Kidney Cyst Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00